Evotec SE - Ordinary Shares, no par value per share (EVO)

31 filings reported holding EVO - Evotec SE - Ordinary Shares, no par value per share as of Q1 2025.
Evotec SE - Ordinary Shares, no par value per share (EVO) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,098,503 shares of 177,507,226 outstanding shares and own 5.1% of the company stock.
Largest 10 shareholders include Mubadala Investment Co PJSC (4,597,701 shares), WELLINGTON MANAGEMENT GROUP LLP (1,903,401 shares), BlackRock, Inc. (1,522,664 shares), DCF Advisers, LLC (751,579 shares), MORGAN STANLEY (88,041 shares), ABC ARBITRAGE SA (77,919 shares), Tower Research Capital LLC (TRC) (41,185 shares), Lighthouse Investment Partners, LLC (37,545 shares), Fore Capital, LLC (17,005 shares), and UBS Group AG (13,620 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.